Answer
Yes, lomitapide mesylate (Lojuxta) is contraindicated in patients with known significant or chronic bowel disease, such as inflammatory bowel disease or malabsorption.
Sources for this answer
- Lojuxta 5mg hard capsulesChiesi Limited · emc · SmPC §4.3 Contraindications · Version 6Document updated
Sources checked